最新消息

News & Message

:::
首頁/
最新消息/
期刊論文/
 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial

最新消息

2025/10/1

 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial

  • An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial
    作者群：曾皓陽(How-Yang Tseng), 馮文生(Wen-Sheng Feng),陳傑龍(Chieh-Lung Chen), 林峻頤(Jiun-Yi Lin), 周敬堯(Ching-Yao Chou), 陳智皓(Chih-Hao Chen), 鄧紀剛(Chi-Kang Teng), 林裕超(Yu-Chao Lin), 沈宜成(Yi-Cheng Shen), 傅昱璋(Yu-Chang Fu), 徐武輝(Wu-Huei Hsu),涂智彥(Chih-Yen Tu), 陳韋成(Wei-Cheng Chen), 周德陽(Der-Yang Cho)
    期刊：Scientific Reports
    出版年月：2025 Oct.
    https://pubmed.ncbi.nlm.nih.gov/41068363/
回上頁

相關文章

 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration
 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration
 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens
 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens
 Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors
 Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂
分享到： 文心一言 百度知道 支付宝 微博 QQ空间 QQ 豆瓣 知乎 CSDN 博客园 简书 百家号 搜狐号 网易号 腾讯
百度 搜狗 360搜索 北青：宋凯到训练场鼓励中国U17，表示后两轮小组赛还有机会 “对等关税”9日生效，美国投资人喊话：开启囤货模式！ 深度理解Manus AI Agent 复盘巴菲特本轮美股牛市的高位逃顶：坚决不赚最后一个铜板，几乎都是8折9折10折大减仓！ 吴镇宇说柯淳短剧挺好看的 
      <code id='75b02'></code><style id='1dbbf'></style>
      • <acronym id='a3f35'></acronym>
      <center id='a9719'><center id='516b2'><tfoot id='b2233'></tfoot></center><abbr id='cccff'><dir id='7c229'><tfoot id='1306d'></tfoot><noframes id='b79c4'>
      • <optgroup id='6141e'><strike id='7ddc3'><sup id='f9f53'></sup></strike><code id='87ac1'></code></optgroup>
        5. <b id='67e39'><label id='12d19'><select id='aff65'><dt id='a8a5f'><span id='5ea8d'></span></dt></select></label></b><u id='69791'></u>
          <i id='4984e'><strike id='19aeb'><tt id='26570'><pre id='92b5d'></pre></tt></strike></i>